SAN FRANCISCO, May 14, 2025 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation…Read More
You might also be interested in reading Exante Aims to Tackle Market Abuse, Integrates Platform with eflow.